Which Prognostic Index is Most Appropriate in the Setting of Delayed Stereotactic Radiosurgery for Brain Metastases?

OBJECTIVES: To determine if five commonly-used prognostic indices (PI)–Recursive Partitioning Analysis (RPA), Score Index for Radiosurgery (SIR), Basic Score for Brain Metastases (BSBM), graded prognostic assessment (GPA), and the diagnosis-specific GPA (DSGPA)— are valid following delay between dia...

Full description

Bibliographic Details
Published in:	Frontiers in Oncology
Main Authors:	Timothy Malouff, Nathan R. Bennion, Vivek Verma, Gabriel A. Martinez, Nathan Balkman, Abhijeet Bhirud, Tanner Smith, Chi Lin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2016-11-01
Subjects:	radiation therapy prognosis Stereotactic radiosurgery brain tumor brain metastases
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00248/full

Similar Items

The Role of Stereotactic Radiosurgery in the Treatment of Large Brain Metastases
by: O. L. Evdokimova, et al.
Published: (2022-10-01)

Survival after Stereotactic Radiosurgery in the Era of Targeted Therapy: Number of Metastases No Longer Matters
by: James de Boisanger, et al.
Published: (2024-05-01)

Stereotactic radiosurgery of brain metastases: a retrospective study
by: Isabella Gruber, et al.
Published: (2023-12-01)

SAFESTEREO: phase II randomized trial to compare stereotactic radiosurgery with fractionated stereotactic radiosurgery for brain metastases
by: J. A. Crouzen, et al.
Published: (2023-03-01)

Stereotactic radiosurgery for brain metastases in a child with extra-skeletal Ewing's sarcoma
by: T. S. Rogova, et al.
Published: (2022-09-01)

Stereotactic radiosurgery for brain metastases from non-uterine Leiomyosarcoma: A retrospective case series
by: Juan J. Cardona, et al.
Published: (2025-10-01)

Pre-operative stereotactic radiosurgery treatment is preferred to post-operative treatment for smaller solitary brain metastases
by: Hamidreza Aliabadi, et al.
Published: (2017-10-01)

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity
by: Giuseppe Minniti, et al.
Published: (2019-04-01)

Preoperative Stereotactic Radiosurgery for Brain Metastases
by: David M. Routman, et al.
Published: (2018-11-01)

Cost-effectiveness of stereotactic radiosurgery for brain metastases: a systematic review
by: Leandro Frederico Luís
Published: (2016-12-01)

Shifting paradigms: whole brain radiation therapy versus stereotactic radiosurgery for brain metastases
by: Ashwin Shinde, et al.
Published: (2019-03-01)

Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis
by: Trasimeni Guido, et al.
Published: (2011-05-01)

Hyper Arc technology for stereotactic radiosurgery treatment of brain metastases
by: Marija Skoblar Vidmar
Published: (2023-06-01)

Hyper Arc technology for stereotactic radiosurgery treatment of brain metastases
by: Marija Skoblar Vidmar
Published: (2023-06-01)

Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01)

Volumetric and spatial changes in brain metastases during stereotactic radiosurgery: a case for off-line adaptive planning
by: Menekse Turna, et al.
Published: (2025-09-01)

Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
by: Jaap D. Zindler, et al.
Published: (2017-07-01)

Stereotactic radiosurgery optimization with hippocampal-sparing in patients treated for brain metastases
by: Laura Burgess, et al.
Published: (2021-01-01)

Stereotactic aspiration alone or Ommaya placement and aspiration followed by stereotactic radiosurgery for cystic brain metastasis: A systematic review and meta-analysis
by: David R. Peters, et al.
Published: (2025-01-01)

Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
by: Justin Leu, et al.
Published: (2023-03-01)

Single fraction stereotactic radiosurgery and fractionated stereotactic radiotherapy provide equal prognosis with overall survival in patients with brain metastases at diagnosis without surgery at primary site
by: Garett Paul Ostdiek-Wille, et al.
Published: (2023-05-01)

Dosimetry study comparing single-isocenter high-definition dynamic radiosurgery with multiple-isocenter cone-based stereotactic radiosurgery in treating multiple brain metastases
by: Tianlong Ji, et al.
Published: (2025-03-01)

Single-Isocenter Volumetric Modulated Arc Therapy vs. CyberKnife M6 for the Stereotactic Radiosurgery of Multiple Brain Metastases
by: Rami A. El Shafie, et al.
Published: (2020-05-01)

What if: A retrospective reconstruction of resection cavity stereotactic radiosurgery to mimic neoadjuvant stereotactic radiosurgery
by: Gueliz Acker, et al.
Published: (2023-03-01)

Corrigendum: Time interval from diagnosis to treatment of brain metastases with stereotactic radiosurgery is not associated with radionecrosis or local failure
by: Justin Leu, et al.
Published: (2023-04-01)

Surgical Resection Followed by Stereotactic Radiosurgery (S+SRS) Versus SRS Alone for Large Posterior Fossa Brain Metastases: A Comparative Analysis of Outcomes and Factors Guiding Treatment Modality Selection
by: Ruth Lau, et al.
Published: (2024-10-01)

Corrigendum: What if: a retrospective reconstruction of resection cavity stereotactic radiosurgery to mimic neoadjuvant stereotactic radiosurgery
by: Gueliz Acker, et al.
Published: (2023-08-01)

Is there an optimal time to administer postoperative stereotactic radiosurgery in patients with brain metastases? A systematic review of the literature and meta‐analysis
by: Anthony Nwankwo, et al.
Published: (2023-12-01)

A Single-Institution Analysis of 126 Patients Treated with Stereotactic Radiosurgery for Brain Metastases
by: Kevin B. Harris, et al.
Published: (2017-05-01)

Stereotactic radiosurgery alone for patients with 16 or more brain metastases: Retrospective single-institution analysis
by: Michael T. Milano, et al.
Published: (2025-04-01)

The growing importance of lesion volume as a prognostic factor in patients with multiple brain metastases treated with stereotactic radiosurgery
by: David M. Routman, et al.
Published: (2018-03-01)

Overall survival following stereotactic radiosurgery for ten or more brain metastases: a systematic review and meta-analysis
by: Hamoun Rozati, et al.
Published: (2023-10-01)

Neoadjuvant stereotactic radiosurgery for brain metastases: Current evidence and clinical perspectives
by: Aybala Nur Ucgul, et al.
Published: (2025-09-01)

Evaluation of Biological Effective Dose in Gamma Knife Staged Stereotactic Radiosurgery for Large Brain Metastases
by: Taoran Cui, et al.
Published: (2022-06-01)

Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis
by: Wentao Tian, et al.
Published: (2023-04-01)

Automatically tracking brain metastases after stereotactic radiosurgery
by: Dylan G. Hsu, et al.
Published: (2023-07-01)

Radiation Necrosis Following Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy with High Biologically Effective Doses for Large Brain Metastases
by: Leonie Johannwerner, et al.
Published: (2023-04-01)

Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases
by: Masanori Hirata, et al.
Published: (2022-12-01)

Single versus multiple fraction stereotactic radiosurgery for medium-sized brain metastases (4-14 cc in volume): reducing or fractionating the radiosurgery dose?
by: Philipp Reinhardt, et al.
Published: (2024-08-01)

Dosimetric and radiobiological evaluation of stereotactic radiosurgery using volumetric modulated arc therapy and dynamic conformal arc therapy for multiple brain metastases
by: Chen-Jun Jiang, et al.
Published: (2025-03-01)